A Comparative Study of Ropivacaine Alone Versus Ropivacaine With Dexmedetomidine in Supraclavicular Brachial Plexus Block
DOI:
https://doi.org/10.17140/RPAOJ-1-107Keywords:
Ropivacaine, Dexmedetomidine, Adjuvant, Supraclavicular brachial plexus blockAbstract
Background and Aims: Supraclavicular brachial plexus block is frequently used procedure to provide anaesthesia and good post-operative analgesia for surgery on upper limb. The purpose of this study was to compare the hemodynamic, sedative and analgesic effects of ropivacaine alone versus ropivacaine given along with dexmedetomidine.
Materials and Methodology: This prospective, randomized and double-blinded study included total 60 patients of either sex with age between 18-60 years posted for various elective upper limb surgery and randomly allocated into 2 equal groups of 30 each. Control Group-R received injection ropivacaine (0.75%) 30 ml plus 1 ml normal saline and Group-RD received injection ropivacaine (0.75%) 30 ml plus dexmedetomidine 25 µg (1 ml) for supraclavicular brachial plexus block using the peripheral nerve stimulator. Sensory and motor block, monitoring of vitals (systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR)), presence of any side effect, Ramsay sedation score and visual analogue scale or visual analog scale (VAS) score were determined every 5 mins in 1st 30 mins and then every 15 mins during 1st hr followed by every 2nd hourly during 24 hrs.
Results: There was no significant difference in the study groups with regards to demographic profile and duration of surgery. The onset of sensory and motor blockade was faster in Group-RD than Group-R. {Onset of sensory block: (Group-R=14.133±1.676 min and Group-RD=12.667± 1.213 min) (p=0.000), Onset of motor block: (Group-R=25.967±2.748 min and Group-RD=23.333±3.467 min) (p=0.002). Also total duration of sensory blockade {Group-R=547.833±26.152 mins, Group-RD=811.667±25.405 mins (p value=0.000)}, motor blockade {Group-R=509.667±24.703 mins, Group-RD=760.667±28.062 mins (p value=0.000)} and number of rescue injections in 24 hrs {Group-R=2.733±0.450, Group-RD=1.400±0.498 (p value=0.000)} was significantly different in 2 groups. There was good haemodynamic stability in both groups. SBP and DBP in Group-R and Group-RD with p values 0.416 and 0.784 were comparable between the groups. The difference was statistically not significant. There was no incidence of any side effects like hypotension and bradycardia in any of the 60 patients.
Conclusion: Dexmedetomidine in a dose of 25 µg added to ropivacaine in supraclavicular brachial block for upper limb surgery significantly shortens the onset time and prolongs the duration of sensory and motor block without producing sedation in patients.
References
Morgan EG, Mikhail MS, Murray MJ. Peripheral Nerve Blocks: Clinical Anaesthesiology. 4th ed. Chap. 17. New Delhi, India: Tata McGraw-Hill; 2009.
Abosedira MA. Adding clonidine or dexmedetomidine to lignocaine during Biers block: A comparative study. J Med Sci. 2008; 8: 660-664. Web site. http://www.docsdrive.com/pdfs/an-sinet/jms/2008/660-664.pdf. Accessed September 13, 2016.
Esmaoglu A, Mizrak A, Akin A, Boyaci A. Addition of dexmedetomidine to lidocaine intravenous regional anaesthe-sia. Eur J Anaesthesia. 2005; 22(6): 447-451. doi: 10.1017/ S0265021505000761
Rutkowska K, Knapik P, Msiolek H. The effect of dexmede-tomidine sedation on brachial plexus block in patients with end-stage renal disease. Eur J Anaesthesiol. 2009; 26: 851-855. doi: 10.1097/EJA.0b013e32832a2244
Gandhi R, Shah A, Patel I. Use of dexmedetomidine along with bupivacaine for brachial plexus block. NJMR. 2012; 2(1): 67-69.
Jun Z, Han W, Wen L, et al. Effect of dexmedetomidine on brachial plexus block with ropivacaine and upper extremity is-chemia-reperfusion (I/R) injury in patients undergoing upper extremity surgery. Zhonghua Ma Zui Xue Za Zhi. 2011; 31(01).
Agarwal S, Aggarwal R, Gupta P. Dexmedetomidine prolongs the effect of bupivacaine in supraclavicular brachial plexus block. J Anaesthesiol Clin Pharmacol. 2014; 30: 36-40. doi: 10.4103/0970-9185.125701
Hickey R, Hoffman JRN, Ramamurthy MSNS. A comparison of ropivacaine 0.5% and bupivacaine 0.5% for brachial plexus block. Anaesthesiology. 1991; 74: 639-642. Web site. http://eu-ropepmc.org/abstract/med/2008942. Accessed September 13, 2016.
Vilho A, Haavisto ET, Huha TM, et al. A clinical and pharma-cokinetic comparison of Ropivacaine and Bupivacaine in axilla-ry plexus block. Anaesth Analg. 1995; 81: 534-538. Web site. http://journals.lww.com/anesthesia-analgesia/Abstract/1995 /09000/A_Clinical_and_Pharmacokinetic_Comparison_of.19. aspx. Accessed September 13, 2016.
Esmaoglu A, Yegenoglu F, Akin A, Yildirim C. Dexmede-tomidine added to levobupivacaine prolongs axillary brachial plexus block. Anesth Analg. 2010; 111: 1548-1551. doi: 10.1213/ ANE.0b013e3181fa3095
Klein SM, Roy A, Grass G, et al. A comparison of 0.5% Bu-pivacaine, 0.5% Ropivacaine and 0.75% Ropivacaine for inter-scalene brachial plexus block. Anaesth Analg. 1998; 87: 1316- 1369. doi: 10.1213/00000539-199812000-00019
Vaghadia H, Chan V, Ganapathy S, Lui A, McKenna J, Zimmer K. A multicentre trial of Ropivacaine 7.5 mg/ml V/s Bupivacaine 5 mg/ml for supraclavicular brachial plexus anaes-thesia. Can J Anaesth. 1999; 46(10): 946-951. doi: 10.1007/ BF03013129
Piangatelli C, De Angelis C, Pecora L, Recanatini F, Cerchiara P, Testasecea D. Ropivacaine and levobupivacaine in the infraclavicular brachial plexus block. Minerva Anaesthesiol. 2006; 72: 217-221.
Anand VG, Kannan M, Thavamani A, Bridgit MJ. Effects of dexmedetomidine added to caudal ropivacaine in paediatric lower abdominal surgeries. Indian J Anaesth. 2011; 55(4): 340- 346. doi: 10.4103/0019-5049.84835 Res Pract Anesthesiol Open J Page 34
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Research and Practice in Anesthesiology (RPA) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.